Filing Details
- Accession Number:
- 0001209191-19-024991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-04-17 16:30:40
- Reporting Period:
- 2019-04-15
- Accepted Time:
- 2019-04-17 16:30:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1557290 | A Stuart Arbuckle | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp\Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-04-15 | 2,592 | $180.95 | 36,272 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-15 | 2,712 | $182.29 | 33,560 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-04-15 | 320 | $183.61 | 33,240 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $180.95 (range $180.47 to $181.33).
- Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $182.29 (range $181.86 to $182.54).
Billionaire Hedge Funds
